Guardian Pharmacy Services (GRDN) reported Q4 earnings Wednesday of $0.19 per diluted share.
Three analysts polled by FactSet expected earnings of $0.22 per diluted share.
The company completed its initial public offering in September 2024.
Revenue for the quarter ended Dec. 31 was $338.6 million, up from $281.1 million a year ago.
Three analysts surveyed by FactSet expected $332.8 million.
The company said it expects full-year 2025 revenue between $1.33 billion and $1.35 billion.
Three analysts polled by FactSet expect $1.34 billion.
Shares of Guardian Pharmacy were down 0.3% in after-hours trading.